Pre-treatment of the beta3-adrenergic receptor agonist BRL37344 reduces in vivo myocardial ischemia/reperfusion injury by improving AMPK and SIRT1 activity and by suppressing mTOR and p70S6K signaling pathways
Ozek, Dilan Askin; Onat, Elif; Sahin, Kazim; Tuzcu, Mehmet; Bozoglan, Merve Yilmaz; Sahna, Engin.